Medios AG (OTCMKTS:MEDOF) Stock Short Interest Report for September

Medios AG (OTCMKTS:MEDOF) was the recipient of a significant increase in short interest in the month of September. As of September 30th, there was short interest totaling 858 shares, an increase of 1,200.0% from the September 15th total of 66 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Medios Stock Performance

MEDOF stock remained flat at C$13.64 during trading on Friday. The company has a 50 day moving average price of C$13.64 and a 200 day moving average price of C$13.64. Medios has a 52-week low of C$13.64 and a 52-week high of C$13.64.

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Medios in a research note on Thursday, August 13th. One research analyst has rated the stock with a Buy rating. According to data from MarketBeat, the company has a consensus rating of “Buy”.

About Medios

Medios AG is a Germany-based specialty pharmaceutical company that supplies medicines and related services for patients with complex, chronic and rare diseases. The company works primarily with pharmacies, medical providers and other healthcare partners, supporting the delivery of therapies that often require specialized handling and coordination.

Its activities include the pharmaceutical supply of specialty medicines and the preparation of patient-specific therapies. Medios focuses on areas such as oncology, autoimmune diseases, neurology and other conditions in which individualized treatment solutions or close pharmaceutical support may be required.

Based in Berlin, Medios serves the German healthcare market through its specialty pharmaceutical platform and pharmacy network.